- Home
- VSEE
VSEE
VSEE HEALTH INC
as 04-04-2025 4:00pm EST
Stocks
| Founded: | 2008 | Country: | United States |
| Employees: | N/A | City: | BOCA RATON |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $5.00 | AVG Volume (30 days): | 54.7K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -6.22 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.10 - $33.08 | Next Earning Date: | 05-15-2025 |
| Revenue: | $8,064,925 | Revenue Growth: | 37.45% |
| Revenue Growth (this year): | 76.1% | Revenue Growth (next year): | 64.83% |
Latest VSEE HEALTH INC News
VSEE Breaking Stock News: Dive into VSEE Ticker-Specific Updates for Smart Investing
PR Newswire
4 days ago
VSee Health Highlights: AI-Powered Telehealth Redefining the $787 Billion Digital Healthcare Market
Business Wire
a month ago
VSee Issues Shareholder Letter Highlighting 2024 Achievements and Strong Growth Outlook for 2025
Business Wire
a month ago
VSee Health Secures $444K County Government Contract, Expanding Market Reach in Public Sector Healthcare
Business Wire
a month ago
VSee Health and LanguageLine Team Up to Boost Telehealth Adoption with Seamless, Scalable Multilingual Care
Business Wire
a month ago
VSee Health Secures $560K Contract to Deploy Virtual Command Center for Major Oncology Network, Strengthening Growth Trajectory in Digital Health Market
Business Wire
2 months ago
VSee Health Announces Contract with Top Kidney Care Provider to Add VSee Workflow to Oracle Cerner EHR
Business Wire
2 months ago
VSee Health Secures $2M Contract Renewal for Neurocritical Care Expansion at Leading Hospital System
TipRanks
2 months ago
VSee Health secures $340K contract to create AI-enabled EHR system
Compare VSEE vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "VSEE VSEE HEALTH INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.